Nucleic acid amplification testing facilitates the detection of disease through specific
genomic sequences and is attractive for point-of-need testing (PONT); in particular, the early …

Currently available nucleic acid testing (NAT)-based assays are complex and time-
consuming, and they require expensive instrumentation and dedicated laboratory spaces for …

Advances in nucleic acid amplification technologies have revolutionized diagnostics for
systemic, inherited, and infectious diseases. Current assays and platforms, however, often …

The complexity of Nucleic acid Amplification Technology (NAT1), comprising sample
preparation, amplification and detection methods, requires specific design considerations for …

Infectious diseases and tumors have become the biggest medical challenges in the 21st
century. They are driven by multiple factors such as population growth, aging, climate …

Designs and applications of microfluidics-based devices for molecular diagnostics (Nucleic
Acid Amplification Tests, NAATs) in infectious disease testing are reviewed, with emphasis …

The ongoing pandemic and increasing frequency of infectious disease outbreaks due to
climate change, urbanization, and global human migration have put great focus on nucleic …

The recurring instances of infectious disease outbreaks, coupled with complications such as
comorbidity challenges and antibiotic resistance, consistently underscore the limitations …

We have developed components of a diagnostic disposable platform that has the dual
purpose of providing molecular diagnostics at the point of care (POC) as well as stabilizing …

Analyses of nucleic acid amplification products are generally performed by the complicated
gel electrophoresis or costly florescence method. In this work, colorimetric detection of …